+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prescription drug products; revocation of patient package insert requirements--Food and Drug Administration. Final rule



Prescription drug products; revocation of patient package insert requirements--Food and Drug Administration. Final rule



Federal Register 47(173): 39147-39155



The Food and Drug Administration (FDA) is revoking its final rule establishing requirements for the preparation and distribution of patient package inserts (PPI's) for prescription drug products for human use. This action is taken because the agency has determined that a mandatory pilot PPI program is unjustifiable, and that it is now preferable to encourage alternative patient information efforts. The agency believes that cooperation with health professionals and others in both the public and private sectors and reliance upon expanding privately sponsored initiatives in patient education should serve to provide patients with needed information about prescription drugs.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 047054141

Download citation: RISBibTeXText

PMID: 10258154


Related references

Prescription drug products; patient package insert requirements--Food and Drug Administration. Final rule. Federal Register 46(1): 28-30, 1980

Food and Drug Administration--Prescription drug products; patient package inserts requirements. Final rule. Federal Register 45(179 Pt 2): 60754-60784, 1980

Prescription drug products that require patient package inserts; ampicillin and phenytoin--Food and Drug Administration. Final rule. Federal Register 46(1): 28-28, 1980

Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures. Food and Drug Administration, HHS. Final rule. Federal Register 64(232): 67720-67763, 2000

Prescription drugs; revocation of final guideline patient package inserts and withdrawal of draft guideline patient package inserts--Food and Drug Administration. Notice. Federal Register 47(173): 39249-39250, 1982

Progestational drug products for human use; requirements for labeling directed to the patient. Food and Drug Administration, HHS. Final rule. Federal Register 64(220): 62110-2, 2000

Exemption from federal preemption of state and local cigarette and smokeless tobacco requirements; revocation. Food and Drug Administration, HHS. Final rule. Federal Register 65(216): 66636-66636, 2001

Human drugs and biologics; determination that informed consent is NOT feasible or is contrary to the best interests of recipients; revocation of 1990 interim final rule; establishment of new interim final rule. Food and Drug Administration, HHS. Interim final rule; opportunity for public comment. Federal Register 64(192): 54180-9, 2000

Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of final monograph for OTC antitussive drug products. Food and Drug Administration, HHS. Final rule. Federal Register 65(148): 46864-8, 2000

Distribution of certain drug products by registered blood establishments and comprehensive hemophilia diagnostic treatment centers that qualify as health care entities; Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements and administrative procedures. Final rule. Federal Register 73(197): 59496-59501, 2008

Revocation of regulation on positron emission tomography drug products--FDA. Final rule; revocation. Federal Register 62(244): 66522-66522, 1997

Medical devices; revocation of cardiac pacemaker registry. Food and Drug Administration, HHS. Final rule. Federal Register 64(226): 66105-6, 2000

The new Food and Drug Administration drug package insert: implications for patient safety and clinical care. Anesthesia and Analgesia 108(1): 211-218, 2009

Topical antifungal drug products for over-the-counter human use; amendment of final monograph. Food and Drug Administration, HHS. Final rule. Federal Register 65(168): 52302-5, 2000

Sunscreen drug products for over-the-counter human use; final monograph. Food and Drug Administration, HHS. Final rule. Federal Register 64(98): 27666-27693, 1999